Skip to main content

Advertisement

Log in

IFN-induced modulation of histocompatibility antigens on human cells

Background, mechanisms and perspectives

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Abstract

IFN proteins are a family of lymphokines with anti-viral effects. Several other effects of IFNs have also been described, including enhancement of natural killer (NK) cell activity, enhancement of cytotoxic T-lymphocyte activity, and enhancement of the expression of major histocompatibility complex (MHC) antigens. The latter effects have been characterized as immunomodulatory, whereas the well-known inhibition of growth of malignant cells has been termed anti-proliferative.

This review summarizes the current knowledge of the enhancement of MHC products by IFNs. Whereas the basic methodologies for demonstrating the enhancement are simple and reliable, especially when using flow cytometry (FCM), the biological relevance of this reaction is largely unknown. Based on recent findings, however, we have hypothesized that the above-mentioned diverse effects of IFNs are all-in some way or other-related to the classical anti-viral mechanism. This concept proposes that the MHC-enhancing effect of IFNs is a vital part of the immunological defense against virus infections and an integral part of the anti-viral effects of IFN proteins.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

2-5A:

2′,5′-oligoadenylate

β2-M:

β2-Microglobulin

dsRNA:

double-stranded RNA

FCM:

Flow Cytofluorometry

IFN:

Interferon

IL-1:

Interleukin-1

IL-2:

Interleukin-2

MHC:

Major Histocompatibility Complex

NK:

Natural Killer

References

  1. Hokland M: Immunomodulatory effects of interferons on human mononuclear cells with special reference to the expression of cell surface antigens. Thesis. Acta Path Microbiol Immunol Scand Sect. C, Suppl. 286, 93: 1–35, 1985

  2. Rosa F, Fellous M: The effect of γ-interferon on MHC antigens. Immunol. Today 5: 261–264, 1984

    Google Scholar 

  3. Sen GC: Biochemical pathways in interferon-action. Pharmac Ther 24: 235–257, 1984

    Google Scholar 

  4. Weissman C, Weber H: The interferon genes. Prog Nucl Acid Res Mol Biol 33: 251–300. Cohn WE, Moldave K (eds) Academic Press, 1986

    Google Scholar 

  5. Weissenbach J, Chernajovsky Y, Zeevi M, Shulman L, Soreq H, Nir U, Wallach D, Perricaudet M, Tiollais P, Revel M: Two interferon mRNAs in human fibroblasts: In vitro translation and Escherichia coli cloning studies. Proc Natl Acad Sci USA 77: 7152–7158, 1980

    Google Scholar 

  6. Sehgal PB, Sagar AD: Heterogeneity of poly(I):poly(C)-induced human fibroblast interferon mRNA species. Nature 288: 95–96, 1980

    Google Scholar 

  7. Revel M, Ruggieri R, Zilberstein A: Expression of human IFN-β 2 genes in rodent cells. In: Schellekens H, StewartII WE (eds) The Biology of the Interferon System. Elsevier, Amsterdam, 1985, pp. 207–216

    Google Scholar 

  8. Moore RN, Larsen HS, Horohov DW, Rouse BT: Endogenous regulation of macrophage proliferative expansion by colony-stimulating factor-induced interferon. Science 233: 178–179, 1984

    Google Scholar 

  9. Van Damme J, DeLey M, Opdenakker G, Billiau A, de Somer P, Van Beeumen J: Homogenous interferon-inducing 22k factor is related to endogenous pyrogen and interleukin 1. Nature 314: 266–268, 1985

    Google Scholar 

  10. Zullo JN, Cochran BH, Huang AS, Stiles CD: Platelet-derived growth factor and double-stranded ribonucleic acids stimulate expression of the same genes in 3T3 cells. Cell 43: 793–799, 1985

    Google Scholar 

  11. Kohase MN, Henriksen-DeStefano D, May LT, Vilcek J, Sehgal PB: Induction of interferon-β 2 by ‘tumor necrosis factor’. A homeostatic mechanism in the control of cell proliferation. Cell 45: 659–663, 1986

    Google Scholar 

  12. Duc-Goiran P, Robert-Galliot B, Lopez J, Chany C: Unusual apparently constitutive interferons and antagonists in human placental blood. Proc Natl Acad Sci USA 82: 5010–5014, 1985

    Google Scholar 

  13. Preble OT, Black RJ, Friedman RM, Klippel JH, Vilcek J: Systemic Lupus Erythematosus: Presence in human serum of an unusual acid-labile leukocyte interferon. Science 216: 429–430, 1982

    Google Scholar 

  14. Week PK, Apperson S, May L, Stebbing N: Comparison of the anti-viral activities of various cloned human interferon-a subtypes in mammalian cell cultures. J Gen Virol 57: 233–241, 1981

    Google Scholar 

  15. Heron I, Hokland M, Berg K: 13 native HuIFN-a species assessed for immunoregulatory properties. J Interferon Res 3: 231–235, 1983

    Google Scholar 

  16. Ortaldo JR, Herberman RB, Harvey C, Osheroff P, Pan Y-CE, Kelder B, Pestka S: A species of human a-interferon that lacks the ability to boost human natural killer activity. Proc Natl Acad Sci USA 81: 4926–4929, 1984

    Google Scholar 

  17. Hiscott J, Cantell K, Weissman C: Differential expression of human interferon genes. Nucl Acid Res 12: 3727–3731, 1984

    Google Scholar 

  18. Bodmer WF: HLA Today. Hum Immunol 17: 490–503, 1985

    Google Scholar 

  19. Peterson PA, Rask L, Östberg L: 205–1-Microblobulin and the major histocompatibility complex. Adv Cancer Res 24: 115–163, 1977

    Google Scholar 

  20. Daar AS, Fuggle SV, Fabre JW, Ting A, Morris PJ: The detailed distribution of HLA-A, B, C antigens in normal human organs. Transplantation 38: 287–291, 1984

    Google Scholar 

  21. Kaufman JF, Auffray C, Korman AJ, Shackelford A, Strominger J: The class II molecules of the human and murine major histocompatibility complex. Cell 36: 1–48, 1984

    Google Scholar 

  22. Radka SF, Charron DJ, Brodsky FM: Class II molecules of the Major Histocompatibility Complex considered as differentiation markers. Human Immunol 16: 390–400, 1986

    Google Scholar 

  23. Schwartz RH: The role of gene products of the Major Histocompatibility Complex in T cell activation and cellular interactions. In: Paul WE (ed) Fundamental Immunology, Raven Press, New York, pp. 379–438, 1985

    Google Scholar 

  24. Lindahl P, Leary P, Gresser I: Enhancement of interferon of the expression of surface antigen on murine leukemia L1210 cells. Proc Natl Acad Sci USA 70: 2785–2788, 1973

    Google Scholar 

  25. Carrel S, Schimdt-Kessen A, Giuffre L: Recombinant interferon-gamma can induce the expression of HLA-DR and DC or DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor associated antigens. Eur J Immunol 15: 118–123, 1985

    Google Scholar 

  26. Lindahl P, Peary P, Gresser I: Enhancement of the expression of histocompatibility antigens of mouse lymphoid cells by IFN in vitro. Eur J Immunol 4: 779–784, 1974

    Google Scholar 

  27. Lindahl P, Gresser I, Leary P, Tovey M: Interferon treatment of mice: enhanced expression of histocompatibility antigens on lymphoid cells. Proc Natl Acad Sci USA 7: 1284–1287, 1976

    Google Scholar 

  28. Heron I, Hokland M, Berg K: Enhanced expression of β2-Microglobulin and HLA antigens on human lymphoid cells by IFN. Proc Natl Acad Sci USA 75: 6215–6218, 1978

    Google Scholar 

  29. Fellous M, Kamoun M, Gresser I, Bono R: Enhanced expression of HLA antigens and β2-Microglobulin on IFN-treated human lymphoid cells. Eur J Immunol 9: 446–449, 1979

    Google Scholar 

  30. Durandy A, Virelizier J-L, Griscelli C: Enhancement by IFN of membrane HLA-antigens in patients with combined immunodeficiency with defective HLA expression. Clin Exp Immunol 52: 173–179, 1983

    Google Scholar 

  31. Attallah AM, Strong DM: Differential effects of Interferon on the MHC expression of human lymphocytes. Enhanced expression of HLA without effect on Ia. Arch Allergy Appl Immunol 60: 101–105, 1979

    Google Scholar 

  32. Hokland M, Heron I, Berg K: Increased expression of β2-Microglobulin and histocompatibility antigens on human lymphoid cells induced by IFN. J IFN Res 1: 483–497, 1981

    Google Scholar 

  33. Dolei A, Ameglio F, Capobianchi MR, Tosi R: Human β-type Interferon enhances the expression and shedding of Ia-like antigens. Comparison to HLA-A,-B,-C and β2-Microglobulin. Anti-viral Res 1: 367–374, 1981

    Google Scholar 

  34. Burrone OR, Milstein C: Control of HLA ABC synthesis and expression in Interferon treated cells. EMBO J 1: 345–349, 1982

    Google Scholar 

  35. Wallach D, Fellous M, Revel M: Preferential effect of γ interferon on the synthesis of HLA antigens and their mRNAs in human cells. Nature 299: 240–245, 1982

    Google Scholar 

  36. Vignaux F, Gresser I: Differential effects of IFN on the expression of H-2K, H-2D and Ia antigens on mouse lymphocytes. J Immunol 118: 721–726, 1977

    Google Scholar 

  37. Imai K, Ng A-K, Glassy MC, Ferrone S: Differential effect of IFN on the expression of tumor-associated antigens and histocompatibility antigens on human melanoma cells: relationship to susceptibility to immune lysis mediated by monoclonal antibodies. J Immunol 127: 505–31, 1981

    Google Scholar 

  38. Basham TY, Bourgeade MF, Creasey AA, Merigan TC: Interferon increases HLA synthesis in melanoma cells: Interferon-resistant and-sensitive lines. Proc Natl Acad Sci USA 79: 3265–3269, 1982

    Google Scholar 

  39. Liao S-K, Kwong PC, Khosravi M, Dent PB: Enhanced expression of melanoma-associated antigens and β2-Microglobulin on cultured human melanoma cells by IFN. J Natl Cancer Inst 68: 19–22, 1982

    Google Scholar 

  40. Pulczynski S, Boesen AM, Myhre Jensen O, Ellegaard J, Hokland P: Immunoelectron microscopy studies on the modulation of CALLA on NALM-6 cells. Leukemia, submitted 1988

  41. Lucero MA, Magdelenat H, Fridman WH, Pouillart P, Billardon C, Billiau A, Cantell K, Falcoff E: Comparison of effects of leukocyte and fibroblast IFN on immunological parameters in cancer patients. Eur J Cancer Clin Oncol 18: 243–247, 1982

    Google Scholar 

  42. Hokland M, Ritz J, Hokland P: Interferon-induced changes in expression of antigens defined by monoclonal antibodies on malignant and non-malignant mononuclear hemato-poietic cells. J Interferon Res 3: 199–209, 1983

    Google Scholar 

  43. Sonnenfeld G, Merullo D, McDevitt HO, Merigan TC: Effect of type I and type II Interferon on murine thymocyte surface antigen expression: induction or selection? Cell Immunol 57: 427–439, 1981

    Google Scholar 

  44. Dolei A, Capobianchi MR, Ameglio F: Human interferon-gamma enhances the expression of class I and class II major histocompatibility complex products in neoplastic cells more effectively than interferon-alpha and interferon-beta. Infect Immunit 40: 172–176, 1983

    Google Scholar 

  45. Virelizier JL, Perex N, Arenzana-Seisdedos F, Devos R: Pure interferon gamma enhances class II HLA antigens on human monocyte cell lines. Eur J Immunol 14: 106–108, 1984

    Google Scholar 

  46. Basham T, Merigan TC: Immunoregulation by γ-Interferon? Nature (London) 299: 778–779, 1982

    Google Scholar 

  47. Basham T, Merigan TC: Recombinant Interferon-γ increases HLA-DR synthesis and expression. J Immunol 130: 1491–1494, 1983

    Google Scholar 

  48. Scher MG, Beller DI, Unanue ER: Demonstration of a soluble mediator that induces exudates rich in Ia + macrophages. J Exp Med 152: 1684–1698, 1980

    Google Scholar 

  49. Steeg PS, Moore R, Oppenheim JJ: Regulation of murine macrophage Ia antigen expression by products of activated spleen cells. J Exp Med 152: 1734–1744, 1980

    Google Scholar 

  50. Steinman RN, Noguerira N, Witmer M, Tydings J, Mellman I: Lymphokine enhances the expression and synthesis of Ia antigens on cultures of mouse peritoneal macrophages. J Exp Med 152: 1248–1261, 1980

    Google Scholar 

  51. Beller DI, Ho I: Regulation of macrophage populations. V. Evaluation of the control of macrophage Ia expression in vitro. J Immunol 129: 971–976, 1982

    Google Scholar 

  52. Calamai E, Beller DI, Unanue ER: Regulation of macrophage populations. IV. Modulation of Ia expression in bone marrow derived macrophages. J Immunol 128: 1692–1694, 1982

    Google Scholar 

  53. Prostowsky MB, Ely JM, Beller DI, Eisenber L, Goldman J: Alloreactive cloned T cell lines. VI. Multiple lymphokine activities secreted by helper and cytolytic cloned T lymphocytes. J Immunol 129: 2337–2344, 1982

    Google Scholar 

  54. Steeg P, Moore RN, Johnson HM, Oppenheim JJ: Regulation of murine macrophage Ia antigen expression by a lymphokine with immune Interferon activity. J Exp Med 156: 1780–1793, 1982

    Google Scholar 

  55. King DP, Jones PP: Induction of Ia and H-2 antigen expression on a macrophage cell line by immune IFN. FED Proc 42: 448–449, 1982

    Google Scholar 

  56. Pober JS, Gimbrone AJr, Cotran RS, Reiss CS, Burakoff SJ, Fiers W, Ault KA: Ia expression by vascular endothelium is inducible by activated T cells and by human γ interferon. J Exp Med 157: 1339–1353, 1983

    Google Scholar 

  57. Pober JS, Colins T, Gimbrone M, Cotran R, Gitlin J, Riers W, Clayberger C, Krensky A, Burakoff S, Reiss C: Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon. Nature 305: 726–729, 1983

    Google Scholar 

  58. Rosa F, Fellous M, Dron M, Tovey MG, Revel M: Presence of an abnormal β2-Microglobulin mRNA in Daudi cells: induction by IFN. Immunogenetics 17: 125–131, 1983

    Google Scholar 

  59. Rosa F, Hata D, Abadie A, Wallach D, Revel M, Fellous M: Differential regulation of HLA-DR mRNAs and cell surface antigens by interferon. EMBO J 2: 1585–1589, 1983

    Google Scholar 

  60. Capkova J, Peknicova J, Hajnicka V, Borecky L: IFN-induced changes in the expression and topography of H-2 antigens and receptors for SRBNC in tumor cells. Folia Biol (Praha) 28: 28–35, 1982

    Google Scholar 

  61. Williams BRG: Biochemical actions. In: Sikora K (ed) Interferon and Cancer. Plenum Press, New York, pp. 33–52, 1983

    Google Scholar 

  62. Johnstone MI, Torrence PF: The role of interferon-induced proteins, double-stranded RNA and 2′5′-oligoadenylate in the interferon mediated inhibition of viral translation. In: Friedman RM (ed) Interferons and interferon inducers. Academic Press, London, pp. 189–201, 1984

    Google Scholar 

  63. Fellous M, Nir U, Wallach D, Merlin G, Rubinstein M, Revel M: Interferon dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells. Proc Natl Acad Sci USA 79: 3082–3086, 1982

    Google Scholar 

  64. Killander D, Lindahl P, Lundin L, Leary P, Gresser I: Relationship between the enhanced expression of histocompatibility antigens on IFN-treated L1210 cells and their position in the cell cycle. Eur J Immunol 6: 56–59, 1976

    Google Scholar 

  65. Pfeffer LM, Wang E, Tamm I: IFN effects on microfilament organization, cellular fibronectin distribution, and cell motility in human fibroblasts. J Cell Biol 85: 9–18, 1980

    Google Scholar 

  66. Pfeffer LM, Tamm I: Effects of α and β IFNs on the size and proliferation of human cells. In: Abstract, The Third Annual International Congress for IFN Research, Miami, FL. November, 1982

  67. Shulman LM, Kamarck ME, Barbosa JA, Ruddle FH: IFN induced surface expression of HLA in LTK-cells transfected with HLA genomic clones. In: Abstracts, The Third Annual International Congress for IFN Research, Miami, FL. November, 1982

  68. Yoshie O, Schmidt H, Reddy ESP, Weissman S, Lengyel P: Mouse Interferons enhance the accumulation of a human HLA RNA and protein in transfected mouse and hamster cells. J Biol Chem 257: 13169–13172, 1982

    Google Scholar 

  69. Hokland M, Hokland P, Heron I, Schlossman SF: Selective effects of α interferon on human T-lymphocyte subsets during mixed lymphocyte cultures. Scand J Immunol 17: 559–576, 1983

    Google Scholar 

  70. Hirsch M-R, Wietzerbin J, Pierres M, Goridis C: Expression of Ia antigens by cultured astrocytes treated with gamma-interferon. Neurosci Lett 41: 199–204, 1983

    Google Scholar 

  71. Fellous M, Bono R, Hyafil F, Gresser I: IFN enhances the amount of membrane-bound beta2-Microglobulin and its release from human Burkitt cells. Eur J Immunol 11: 524–526, 1981

    Google Scholar 

  72. Zinkernagel RM, Doherty PC: Restriction of in vitro T-cell mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 248: 701–702, 1974

    Google Scholar 

  73. Eager KB, Williams J, Breiding D, Pan S, Knowles B, Appella E, Picciardi RP: Expression of histocompatibility antigens H-2K,-D, and-L is reduced in adenovirus-12 transformed mouse cells and is restored by interferon γ. Proc Natl Acad Sci USA 82: 5525–5529, 1985

    Google Scholar 

  74. Tanaka K, Isselbacher KJ, Khoury G, Jay G: Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene. Science 228: 226–230, 1985

    Google Scholar 

  75. Wallich R, Bulbuc N, Hammerling GJ, Katzav S, Selga S, Feldman M: Abrogation of metastatic properties of tumor cells by de novo expression of H-2K antigens following H-2 gene transfection. Nature 325: 301–305, 1985

    Google Scholar 

  76. Sztein MB, Steeg PS, Steihm R, Maun D, Blaese M, Oppenheim JJ: Modulation of human cord blood monocyte DR antigen expression in vitro by lymphokines and Interferon. In: Oppenheim JJ, Cohen S (eds) Interleukins, Lymphokines and Cytokines. Academic Press, New York, pp. 299–305, 1983

    Google Scholar 

  77. Steeg PS, Johnson HM, Oppenheim JJ: Regulation of murine macrophage Ia antigen expression by an immune Interferon-like lymphokine: inhibitory effect of endotoxin. J Immunol 129: 2402–2406, 1982

    Google Scholar 

  78. Unanue ER, Beller DI, Lu CY, Allen PM: Antigen presentation: comments on its regulation and mechanism. J Immunol 132: 1–5, 1984

    Google Scholar 

  79. Bottazzo GF, Pujol-Borrell R, Hanafusl T: Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet ii: 115–118, 1983

    Google Scholar 

  80. Wong GHW, Bartlett PF, Clark-Lewis I, Battye F, Schrader JW: Inducible expression of H-2 and Ia antigens on brain cells. Nature 310: 668–690, 1984

    Google Scholar 

  81. Meuer SC, Schlossman SF, Reinherz EL: Clonal analysis of human cytotoxic T lymphocytes: T4 + and T8 + effector T regions. Proc Natl Acad Sci USA 79: 4395–4399, 1982

    Google Scholar 

  82. Trinchieri G, Santoli D: Anti-viral activity induced by culturing lymphocytes with tumour-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J Exp Med 147: 1314–1333, 1978

    Google Scholar 

  83. Trinchieri G, Granato D, Perussia B: Interferon-induced resistance of fibroblasts to cytolysis mediated by natural killer cells: specificity and mechanism. J Immunol 126: 335–340, 1981

    Google Scholar 

  84. Nathan CF, Murray HW, Wiebe ME, Rubin BY: Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 158: 670–689, 1983

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hokland, M., Basse, P., Justesen, J. et al. IFN-induced modulation of histocompatibility antigens on human cells. Cancer Metast Rev 7, 193–207 (1988). https://doi.org/10.1007/BF00047751

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00047751

Key words

Navigation